Dr. Roya Mohammadi Mey Abadi | Psoriasis Treatment innovations | Editorial Board Member 

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Dr.Roya Mohammadi Mey Abad | Psoriasis treatment innovations| Editorial Board Member 

Ph. D | University of Barcelona | Spain

Dr. Roya Mohammadi Mey Abadi is a biotechnology researcher specializing in nanobiotechnology and advanced topical drug delivery systems, with a strong focus on psoriasis treatment innovations. Her work centers on the development of lipid-based and polymeric nanosystems designed to enhance skin penetration, improve drug stability, and reduce systemic side effects in inflammatory and autoimmune dermatological disorders. She has contributed to pioneering research on baricitinib nanoformulations for psoriasis, atopic dermatitis, and related immune-mediated conditions, advancing targeted therapeutic strategies in dermatology. As a researcher affiliated with the Faculty of Pharmacy and Food Sciences and an Editorial Board Member in pharmaceutical sciences, Dr. Mey Abadi actively supports high-impact translational research. With an h-index of 1 and emerging citation impact, her scholarly contributions reflect a growing influence in dermatological nanomedicine. Her research vision aims to bridge nanotechnology and clinical dermatology to deliver safer, more effective, and globally accessible therapeutic solutions for chronic skin diseases.

Citation Metrics (Scopus)

100

10

5

0

Citations
64

Documents
5

h-index
2

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View ORCID profile

Featured Publications


Assessing the solubility of baricitinib and drug uptake in different tissues using absorption and fluorescence spectroscopies

R Mohammadi-Meyabadi, N Beirampour, N Garrós, HL Alvarado, ...
Pharmaceutics 14 (12), 2714

Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome

N Garrós, M Mallandrich, N Beirampour, R Mohammadi, Ò Domènech, ...
Pharmaceutics 14 (9), 1895

Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application

N Beirampour, P Bustos-Salgado, N Garrós, R Mohammadi-Meyabadi, ...
Pharmaceutics 16 (8), 1092

Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment
–. Baricitinib lipid-based nanosystems as a topical alternative for atopic dermatitis treatment

Lipid-based formulation of baricitinib for the topical treatment of psoriasis

R Mohammadi-Meyabadi, M Mallandrich, N Beirampour, N Garrós, ...
Pharmaceutics 16 (10), 1287

Dr. Mirjana Popadic | Skin Cancer Prevention | Best Researcher Award

Dr. Mirjana Popadic | Skin Cancer Prevention | Best Researcher Award

Dermatologist-Oncologist | Medigroup | Serbia

Dr. Mirjana Popadic is a researcher affiliated with the University of Belgrade, Serbia, where she has established a growing academic profile in her field.  Over her career, Dr. Popadic has authored 15 scholarly publications, which have collectively received 121 citations from 99 documents, demonstrating the steady influence of her contributions and culminating in an h-index of 7. Her work spans several key research domains, reflecting interdisciplinary strength and a commitment to advancing scientific understanding within her specialty. Through collaborations with at least nine co-authors, she has contributed to studies that highlight collaborative scientific inquiry and cross-disciplinary relevance. Her publications, indexed in reputable international venues, cover impactful themes aligned with contemporary scientific priorities, positioning her as an emerging scholar whose research continues to gain recognition within the academic community. Although no awarded grants or editorial roles are listed in the provided record, her publication performance and citation trajectory underscore her potential for expanded leadership roles in future scientific initiatives. Dr. Popadics scholarly output reflects methodological rigor, thematic relevance, and a commitment to addressing meaningful research questions. Her growing citation footprint indicates that her work is not only referenced but also utilized by peers for further advancements, contributing to broader scientific development. Through her contributions at the University of Belgrade, she continues to support the advancement of knowledge, strengthen collaborative networks, and contribute to the international visibility of Serbian research. With sustained productivity and a demonstrated record of influence, Dr. Popadic represents a dedicated academic whose work carries both scientific and societal impact.

Profiles: Scopus | ORCID

Featured Publications

1. Popadić, M. (2018). Dermatoscopy of multiple piloleiomyomas with disseminated and segmental distribution. Indian Journal of Dermatology, Venereology and Leprology.

2. Popadić, M. (2018). Cutaneous Polyarteritis Nodosa: Uncommon and Rare Form of Cutaneous Vasculitis. Serbian Journal of Dermatology and Venereology.

3. Popadić, M. (2015). Dermoscopy of aggressive basal cell carcinomas. Indian Journal of Dermatology, Venereology and Leprology.

4. Popadić, M., & Vukićević, J. (2015). What is the impact of tumour size on dermoscopic diagnosis of BCC? Journal of the European Academy of Dermatology and Venereology.

5. Popadić, M. (2015). Dermoscopy of cutaneous Abrikossoff tumor (granular cell tumor) in a pediatric patient. Journal of the American Academy of Dermatology.